Maximum Testosterone Dose for Adult Males with Testosterone Deficiency
The maximum recommended dose of testosterone cypionate or enanthate is 400 mg administered intramuscularly every 2-4 weeks, though therapy should target mid-normal testosterone levels (450-700 ng/dL) rather than maximizing dose. 1
Dosing Framework Based on Formulation
The approach to testosterone dosing is not about finding a "maximum" but rather achieving mid-normal serum testosterone levels during treatment. The Endocrine Society guidelines explicitly state that therapy should aim for testosterone levels in the mid-normal range, with dose adjustments made when levels exceed 700 ng/dL or fall below 400 ng/dL 2, 3.
Injectable Testosterone (Enanthate/Cypionate)
Recommended dosing ranges:
- 75-100 mg IM weekly, OR
- 150-200 mg IM every 2 weeks, OR
- 300 mg IM every 3 weeks 3
FDA-approved maximum: 50-400 mg every 2-4 weeks 1
The higher end (400 mg every 4 weeks) is FDA-approved but often less effective clinically. Studies demonstrate that 200 mg every 2 weeks or 300 mg every 3 weeks are most effective for suppressing LH to normal levels while maintaining stable testosterone concentrations 4. The 400 mg every 4 weeks regimen failed to adequately suppress LH in clinical trials, suggesting suboptimal efficacy 4.
Transdermal Formulations
Other Formulations
- Buccal tablets: 30 mg every 12 hours 3
- Testosterone undecanoate (IM): 750-1000 mg every 10-12 weeks 5, 6
Critical Monitoring Thresholds (Safety Limits)
You must stop or reduce testosterone when:
- Testosterone level >700 ng/dL (24.5 nmol/L) midway between injections → reduce dose or frequency 2, 3
- Hematocrit >54% → stop therapy until hematocrit decreases, evaluate for hypoxia/sleep apnea, then reinitiate at reduced dose 2, 3
- Hematocrit >50% at baseline is a relative contraindication as these men often develop hematocrit >54% on treatment 2
Monitoring Algorithm
At 3-6 months after initiation:
- Measure testosterone level midway between injections (for injectables)
- Check hematocrit
- Assess symptom response
If testosterone >700 ng/dL: Reduce dose or increase dosing interval
If testosterone <400 ng/dL: Increase dose or decrease dosing interval
Target range: 450-700 ng/dL (mid-normal) 2, 7, 8
Important Clinical Nuances
The concept of a "maximum dose" is somewhat misleading in testosterone therapy. The goal is physiologic replacement, not supraphysiologic dosing. Research shows dose-dependent increases in muscle mass, strength, and hemoglobin up to 600 mg weekly in experimental settings 9, but such doses produce supraphysiologic levels and are inappropriate for clinical testosterone replacement.
Common pitfall: Clinicians sometimes escalate doses excessively when patients don't respond symptomatically. However, if symptoms don't improve with mid-normal testosterone levels, the issue is likely not testosterone deficiency, and further dose escalation increases harm without benefit 10.
The 2010 Endocrine Society guideline (most recent comprehensive guideline) emphasizes that more frequent, lower doses produce more stable levels than infrequent high doses 2. For example, 100 mg weekly provides better LH suppression and more stable testosterone levels than 400 mg monthly 4.
Practical recommendation: Start with 100 mg IM weekly or 200 mg every 2 weeks, measure levels at 3 months, and adjust to achieve mid-normal range. Rarely should doses exceed 200 mg every 2 weeks for maintenance therapy in typical hypogonadal men.